Literature DB >> 26715065

Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.

Michelle D Reid, Pelin Bagci, Nobuyuki Ohike, Burcu Saka, Ipek Erbarut Seven, Nevra Dursun, Serdar Balci, Hasan Gucer, Kee-Taek Jang, Takuma Tajiri, Olca Basturk, So Yeon Kong, Michael Goodman, Gizem Akkas, Volkan Adsay.   

Abstract

Entities:  

Year:  2016        PMID： 26715065     DOI： 10.1038/modpathol.2015.124

Source DB:  PubMed          Journal:  Mod Pathol        ISSN： 0893-3952            Impact factor:   7.842


× No keyword cloud information.
  5 in total

1.  Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.

Authors:  Somak Roy; William A LaFramboise; Ta-Chiang Liu; Dengfeng Cao; Alyssa Luvison; Caitlyn Miller; Maureen A Lyons; Roderick J O'Sullivan; Amer H Zureikat; Melissa E Hogg; Allan Tsung; Kenneth K Lee; Nathan Bahary; Randall E Brand; Jennifer S Chennat; Kenneth E Fasanella; Kevin McGrath; Marina N Nikiforova; Georgios I Papachristou; Adam Slivka; Herbert J Zeh; Aatur D Singhi
Journal:  Gastroenterology       Date:  2018-03-02       Impact factor: 22.682

Review 2.  [Grading of neuroendocrine tumors].

Authors:  W Saeger; P A Schnabel; P Komminoth
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

3.  Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements.

Authors:  Sarag A Boukhar; Matthew D Gosse; Andrew M Bellizzi; Anand Rajan K D
Journal:  Am J Clin Pathol       Date:  2021-09-08       Impact factor: 2.493

4.  Development of a reliable and accurate algorithm to quantify the tumor immune stroma (QTiS) across tumor types.

Authors:  Rainer Christoph Miksch; Jingcheng Hao; Markus Bo Schoenberg; Katharina Dötzer; Friederike Schlüter; Maximilian Weniger; Shuai Yin; Steffen Ormanns; Jan Goesta D'Haese; Markus Otto Guba; Jens Werner; Barbara Mayer; Alexandr V Bazhin
Journal:  Oncotarget       Date:  2017-12-04

5.  Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.

Authors:  Wenzel M Hackeng; Lodewijk A A Brosens; Christopher M Heaphy; Aatur D Singhi; Joo Young Kim; Roderick O'Sullivan; You-Na Sung; Ta-Chiang Liu; Dengfeng Cao; Michelle Heayn; Jacqueline Brosnan-Cashman; Soyeon An; Folkert H M Morsink; Charlotte M Heidsma; Gerlof D Valk; Menno R Vriens; Els Nieveen van Dijkum; G Johan A Offerhaus; Koen M A Dreijerink; Herbert Zeh; Amer H Zureikat; Melissa Hogg; Kenneth Lee; David Geller; J Wallis Marsh; Alessandro Paniccia; Melanie Ongchin; James F Pingpank; Nathan Bahary; Muaz Aijazi; Randall Brand; Jennifer Chennat; Rohit Das; Kenneth E Fasanella; Asif Khalid; Kevin McGrath; Savreet Sarkaria; Harkirat Singh; Adam Slivka; Michael Nalesnik; Xiaoli Han; Marina N Nikiforova; Rita Teresa Lawlor; Andrea Mafficini; Boris Rusev; Vincenzo Corbo; Claudio Luchini; Samantha Bersani; Antonio Pea; Sara Cingarlini; Luca Landoni; Roberto Salvia; Massimo Milione; Michele Milella; Aldo Scarpa; Seung-Mo Hong
Journal:  Gut       Date:  2021-04-13       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.